Following its latest authorization in the Continent , ACE-031 1mg is experiencing notable demand . Sales figures indicate a increasing trend among healthcare professionals , particularly in France . Limitations surrounding reimbursement remain, and are currently being managed by the manufacturer through ongoing dialogues with regulatory bodies . Th